Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Reaches New 12-Month High – What’s Next?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)’s share price reached a new 52-week high during trading on Tuesday . The company traded as high as $10.50 and last traded at $10.35, with a volume of 37248 shares changing hands. The stock had previously closed at $10.00.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. KGaA in a research note on Monday, February 3rd.

Fresenius SE & Co. KGaA Trading Up 3.5 %

The firm has a market capitalization of $23.12 billion, a PE ratio of 49.29 and a beta of 1.02. The company’s fifty day simple moving average is $9.41 and its 200-day simple moving average is $9.23. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.18 earnings per share for the quarter. The company had revenue of $6.01 billion during the quarter. As a group, sell-side analysts expect that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.